Skip to main content
Carcinogenesis logoLink to Carcinogenesis
. 2019 Apr 29;40(2):e16. doi: 10.1093/carcin/bgz056

Retraction: Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells

I-Lu Lai, Chih-Chien Chou, Po-Ting Lai, Chun-Sheng Fang, Lawrence A Shirley, Ribai Yan, Xiaokui Mo, Mark Bloomston, Samuel K Kulp, Tanios Bekaii-Saab, Ching-Shih Chen
PMCID: PMC6778455  PMID: 31034565

Carcinogenesis, 35, 2203–2213. https://doi.org/10.1093/carcin/bgu124

Carcinogenesis is retracting this paper following an institutional investigation conducted by The Ohio State University in response to concerns related to possible image manipulation.

Following the institution’s review, The Ohio State University determined that the images for Figures 1D, and 5A were intentionally falsified by Dr Ching-Shih Chen. Given the presence of falsified data in these figures, the University has requested that the publication be retracted.

Dr Chen formally consented to this retraction during the institutional investigation, and the Journal has more recently received agreement for the retraction from Samuel Kulp, Lawrence Shirley, Mark Bloomston and Tanios Bekaii-Saab. Carcinogenesis has not received responses from the remaining authors and/or has been unable to trace their current affiliations despite numerous attempts. The Journal understands that attempts were made to contact all authors during the institutional investigation.


Articles from Carcinogenesis are provided here courtesy of Oxford University Press

RESOURCES